Pamicell, Top Search Ranking... Stock Price -2.02%
Pamisell has ranked among the top searched stocks on 6 days within the past month.
As of 2:34 PM on the 4th, Pamisell is trading at 16,950 KRW, down 2.02% from the previous day. This represents a 22.43% decrease compared to December 3rd. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net sellers of 63,000 shares. Over the past 5 days, individual investors have net sold 176,291 shares, while foreigners and institutions have net bought 144,120 shares and 14,853 shares, respectively.
On December 28th, Pamisell was a market issue due to a decline amid suspicions of 'unauthorized freezing' of stem cell therapy products.
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Another Attack at a Popular Japanese Restaurant"...Three Injured in Shanghai Stabbing Rampage
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
